Rick Hippert

Rick Hippert serves as the Executive Director at Autolus Ltd. since July 2023, following a role as Senior Director of Medical Affairs at Adaptimmune from July 2022 to July 2023. Previous experience includes positions such as Field Director of Medical Affairs at ADC Therapeutics and National Director of Field Medical Affairs - Oncology Early Development at Daiichi Sankyo, Inc. Rick's background also features significant roles at Kite Pharma and Celgene, where responsibilities included leading US Medical Affairs and managing Medical Science Liaisons. Earlier in the career, roles included Regional Medicine Manager at Boehringer Ingelheim Pharmaceuticals and Area Medical Manager at sanofi-aventis, with foundational experience at Genentech and Sanofi-aventis. Rick holds a PharmD from the University of Arkansas for Medical Sciences and an MBA from Texas Wesleyan University.